Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12083107 Pharmaceutical compositions comprising glitazones and Nrf2 activators

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Bjoern Colin Kahrs0

Date of Patent

September 10, 2024

0

Patent Application Number

180496520

Date Filed

October 26, 2022

0

Patent Citations

US Patent 8129429 Synthetic triterpenoids and methods of use in the treatment of disease

0

US Patent 6858750 Use of fumaric acid derivatives for treating mitochondrial diseases

0

US Patent 7157423 Fumaric acid amides

0

US Patent 7223761 Salts and polymorphs of a potent antidiabetic compound

0

US Patent 7320999 Dimethyl fumarate for the treatment of multiple sclerosis

0

US Patent 7435755 CDDO-compounds and combination therapies thereof

0

US Patent 7601841 Quinolinyl and benzothiazolyl modulators

0

US Patent 7619001 Utilization of dialkylfumarates

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

Patent abstract

The invention relates to pharmaceutical compositions comprising PPAR agonists and Nrf2 activators and methods of using combinations of PPAR agonists and Nrf2 activators for treating diseases such as psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, and arthritis.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12083107 Pharmaceutical compositions comprising glitazones and Nrf2 activators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.